About NextCure (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Through its Functional, Integrat... Read more
- USD1.40
- USD1.58
- USD1.39
- USD2.57
- -40.70%
- --
- 151.12k
- 38M
- 0.98
- -12.20%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
